Senegal

in page functions
[French]
Total population (2015) 15,129,268
Birth cohort (2015) 567,336
Surviving Infants (surviving to 1 year per year, 2015) 545,338
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 42/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 47/1000
World Bank Index, IDA (2012) 3.68
Gross Nation Income (per capita US$, 2014) 1,050
Co-financing status (2016) Preparatory transition
No. of districts/territories (2014) 76

Gavi support for Senegal

Type of support

Approvals

2001-2020 (US$)
(30 Nov 2015)

Commitments

2001-2020 (US$)
(30 Nov 2015)

Disbursements

2000-2015 (US$)
(30 Nov 2015)

% Disbursed

(30 Nov 2015)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Cash Support (CASHSUPP) $145,000 $170,000 $145,000 100%
Health system strengthening (HSS 1) $3,585,500 $3,585,500 $3,585,500 100%
Health system strengthening (HSS 2) $5,759,444 $13,439,369
HepB mono (NVS) $588,743 $588,743 $588,743 100%
HPV Demo (NVS) $144,832 $144,832 $142,609 98%
Immunisation services support (ISS) $2,605,740 $2,605,740 $2,605,740 100%
Injection safety support (INS) $619,474 $619,474 $619,474 100%
IPV (NVS) $2,955,180 $3,914,180 $2,237,680 76%
Measles (NVS) $399,000 $399,000 $221,169 55%
Measles-Rubella (NVS) $4,495,177 $4,495,177 $4,495,177 100%
Meningitis A - campaign (NVS) $2,670,736 $2,670,736 $2,670,736 100%
Meningitis A - operational costs (OPC) $2,567,107 $2,567,107 $2,567,107 100%
MR - Operational costs (OPC) $4,158,500 $4,158,500 $4,158,500 100%
Penta (NVS) $43,222,044 $43,222,044 $39,947,590 92%
Pneumo (NVS) $25,561,285 $25,561,285 $24,233,675 95%
Rotavirus (NVS) $5,835,221 $5,835,221 $3,326,104 57%
Vaccine Introduction Grant (VIG) $2,202,000 $2,202,000 $2,202,000 100%
Total $107,514,985 $116,178,909 $93,746,804

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Senegal DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2014)

Grade of confidence


N/A
DTP3 - Official country estimates (2014) 89%
M:F sex ratio at birth (2015) 1.04
Household survey: DTP3 coverage for male (2013) 88.90%
Household survey: DTP3 coverage for female (2013) 88.10%
Household survey: Last DTP3 survey (2013) 89%
% districts achieving > 80% DTP3 coverage (2014) 58%
% districts achieving < 50% DTP3 coverage (2014) 16%
MCV WHO/UNICEF estimates (2014) 80%

Breakdown of support

Non-vaccine support Vaccine support
17% 83%
$15,459,821 $77,863,479

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Senegal

10 November 2015

Gavi item

Scientists mark 'stunning success' of vaccine in virtually ridding Africa of meningitis A

New research forecasts a resurgence of meningitis A epidemics in 15 years should immunization efforts stall.

26 June 2015

Cote d Ivoire - IPV launch

Enhanced polio protection to reach 650,000 Côte d’Ivoire children every year

Côte d’Ivoire is introducing the inactivated polio vaccine (IPV) into its routine immunisation programme.

25 June 2015

Dr Seth Berkley, CEO of Gavi; Bill Gates Co-Chair of the Bill & Melinda Gates, Laurent Fabius, Minister of Foreign Affairs and International Development, Jean-Marc Gravellini, Executive Director in charge of Operations of the AFD.

Health in the Sahel region, together to improve immunisation programmes

The AFD, the Bill and Melinda Gates Foundation and Gavi signed an Initiative to increase coverage rates in six Sahel countries.

close icon

modal window here